Total Payments
$2,642
2024 Payments
$1,140
Companies
25
Transactions
128
Medicare Patients
1,990
Medicare Billing
$154,287
Payment Breakdown by Category
Food & Beverage$2,613 (98.9%)
Education$29.60 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,613 | 127 | 98.9% |
| Education | $29.60 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $556.69 | 36 | $0 (2024) |
| Novo Nordisk Inc | $440.03 | 18 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $303.32 | 5 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $256.48 | 6 | $0 (2024) |
| PFIZER INC. | $235.18 | 19 | $0 (2024) |
| Corcept Therapeutics | $220.33 | 7 | $0 (2024) |
| Lilly USA, LLC | $72.06 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $66.99 | 4 | $0 (2024) |
| Antares Pharma, Inc. | $53.42 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $51.26 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,140 | 75 | ABBVIE INC. ($373.67) |
| 2023 | $612.48 | 25 | Janssen Pharmaceuticals, Inc ($218.60) |
| 2022 | $485.38 | 24 | Novo Nordisk Inc ($174.78) |
| 2021 | $404.47 | 4 | Teva Pharmaceuticals USA, Inc. ($249.87) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: Obesity | ||||||
| 12/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/06/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: RETT SYNDROME | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: PAIN | ||||||
| 11/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Biological | ||||||
| 10/24/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Endocrinology | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: PAIN | ||||||
| 10/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.84 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.21 | General |
| 09/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/30/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Obesity | ||||||
| 08/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: Endocrinology | ||||||
| 08/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Obesity | ||||||
| 08/16/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: PAIN | ||||||
| 08/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: PAIN | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 457 | 1,466 | $173,253 | $36,374 |
| 2022 | 17 | 594 | 1,625 | $122,801 | $41,938 |
| 2021 | 14 | 505 | 1,767 | $106,487 | $51,475 |
| 2020 | 12 | 434 | 561 | $60,943 | $24,499 |
Total Patients
1,990
Total Services
5,419
Medicare Billing
$154,287
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 12 | 841 | $80,030 | $14,422 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 171 | 232 | $29,112 | $9,202 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 144 | $25,200 | $6,210 | 24.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 61 | $14,945 | $2,938 | 19.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 29 | 35 | $14,910 | $1,935 | 13.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 14 | $4,228 | $735.82 | 17.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 30 | 63 | $3,276 | $550.22 | 16.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 17 | 19 | $931.00 | $307.80 | 33.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 16 | 44 | $399.75 | $45.55 | 11.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 13 | $221.00 | $28.60 | 12.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 13 | 901 | $27,030 | $15,560 | 57.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 158 | 218 | $27,588 | $8,981 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 158 | $26,070 | $6,461 | 24.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 60 | 79 | $17,459 | $4,275 | 24.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 19 | 19 | $8,094 | $1,619 | 20.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 21 | 22 | $6,644 | $1,262 | 19.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 18 | 18 | $1,206 | $1,182 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 23 | $1,012 | $642.85 | 63.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $830.00 | $436.63 | 52.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 25 | 25 | $875.00 | $384.35 | 43.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 30 | 44 | $2,288 | $349.48 | 15.3% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2022 | 24 | 27 | $972.00 | $231.40 | 23.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 14 | 14 | $686.00 | $227.94 | 33.2% |
| 69209 | Removal of impacted ear wax by washing | Office | 2022 | 15 | 17 | $660.00 | $180.29 | 27.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $936.00 | $98.24 | 10.5% |
About Donna Goodwin, APRN, CNP
Donna Goodwin, APRN, CNP is a Family healthcare provider based in Avon, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2017. The National Provider Identifier (NPI) number assigned to this provider is 1295255610.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Donna Goodwin, APRN, CNP has received a total of $2,642 in payments from pharmaceutical and medical device companies, with $1,140 received in 2024. These payments were reported across 128 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,613).
As a Medicare-enrolled provider, Goodwin has provided services to 1,990 Medicare beneficiaries, totaling 5,419 services with total Medicare billing of $154,287. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Avon, OH
- Active Since 06/27/2017
- Last Updated 07/21/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1295255610
Products in Payments
- UBRELVY (Drug) $279.47
- AJOVY (Biological) $268.30
- SPRAVATO (Drug) $256.48
- Korlym (Drug) $220.33
- VRAYLAR (Drug) $206.19
- Wegovy (Drug) $159.49
- NURTEC ODT (Drug) $124.30
- Saxenda (Drug) $120.02
- Ozempic (Drug) $62.64
- QULIPTA (Drug) $44.21
- Dexcom G6 Transmitter (Medical Supply) $38.76
- GVOKE HYPOPEN (Drug) $38.54
- NOCDURNA (Drug) $38.46
- BREZTRI (Drug) $36.88
- Rybelsus (Drug) $35.60
- AirDuo Digihaler (Drug) $35.02
- SHINGRIX (Biological) $34.42
- ELIQUIS (Drug) $33.25
- TRELEGY ELLIPTA (Drug) $32.57
- Veozah (Drug) $32.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Avon
Sarah Diamond, Cnp, CNP
Family — Payments: $3,632
Family $3,632
Jennifer Pyrro, Aprn, APRN
Family — Payments: $2,801
Family $2,801
Mrs. Aubrey Shearn, Fnp-C, FNP-C
Family — Payments: $2,593
Family $2,593
Tyler Kelly, Np, NP
Family — Payments: $2,412
Family $2,412
Mrs. Stephanie Fernald, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $2,174
Family $2,174
Janice Whedon, Aprn, APRN
Family — Payments: $2,097
Family $2,097